Table 1.
Nonparametric assessment of the correlations between clinicopathological factors and RRM2-C2orf48 expression levels in 74 patients with lung cancer
| Clinical Characteristic | Number of patients (n = 74) | RRM2-C2orf48 expression Mean ± SD | P-value |
|---|---|---|---|
| Age (years) | 0.897 | ||
| ≥60 | 38 | 5.47 ± 3.43 | |
| <60 | 36 | 5.82 ± 3.76 | |
| Gender | 0.292 | ||
| Male | 48 | 5.95 ± 3.75 | |
| Female | 26 | 5.06 ± 3.21 | |
| T stage | 0.881 | ||
| T1-2 | 4 | 6.59 ± 5.48 | |
| T3-4 | 70 | 5.58 ± 3.49 | |
| N stage | <0.001 | ||
| N0 | 44 | 4.42 ± 3.04 | |
| N1-2 | 30 | 7.53 ± 3.56 | |
| M stage | <0.001 | ||
| M0 | 64 | 4.91 ± 2.76 | |
| M1 | 10 | 10.34 ± 4.70 | |
| TNM stage | <0.001 | ||
| I–II | 37 | 3.49 ± 1.69 | |
| III–IV | 37 | 7.79 ± 3.67 | |
| Histological subtype | 0.96 | ||
| LUSC | 29 | 5.52 ± 2.84 | |
| LUAD | 40 | 4.96 ± 2.96 | |
| SCLC | 4 | 13.13 ± 6.33 | |
| LCLC | 1 | 6.37 ± 0 | |
| Largest tumor dimension (cm) | 0.604 | ||
| >3.0 | 38 | 5.75 ± 3.48 | |
| ≤3.0 | 36 | 5.52 ± 3.71 | |
| Smoking history | 0.001 | ||
| Smoker | 32 | 7.00 ± 3.70 | |
| Nonsmoker | 42 | 4.60 ± 3.14 |